Dec. 13, 2009 – Accenture (NYSE: ACN) today announced that it will not continue its sponsorship agreement with Tiger Woods.
For the past six years, Accenture and Tiger Woods have had a very successful sponsorship arrangement and his achievements on the golf course have been a powerful metaphor for business success in Accenture’s advertising. However, given the circumstances of the last two weeks, after careful consideration and analysis, the company has determined that he is no longer the right representative for its advertising. Accenture said that it wishes only the best for Tiger Woods and his family.
Accenture will continue to leverage its “High Performance Business” strategy and “High Performance Delivered” positioning in the marketplace. The company will immediately transition to a new advertising campaign, with a major effort scheduled to launch later in 2010. Read more…
Viewed 67005 times by 1260 viewers
November 2009 – Sydney, Australia: A study by Germany’s Greifswald University has confirmed the outstanding performance of Gelcompany’s High Performance Electrophoresis (HPE) system.
HPE comprises innovative consumables and equipment that enable scientists to better measure biological processes using horizontal high performance electrophoresis.
Gelcompany, the wholly owned subsidiary of Fluorotechnics (ASX: FLS), commissioned Greifswald’s University Institute for Microbiology headed by Prof. Michael Hecker (contact: Mr Knut Buettner) to conduct the study to evaluate the new HPE system against the current forms of electrophoresis methodology at one of the world’s leading proteomic research facilities. Read more…
Viewed 20610 times by 551 viewers
- Joint Project Funding and Development agreement signed by m2m
- m2m targets initial annual income streams of $4M from long life projects
m2m Corporation Limited (“m2m”) (ASX: “MCL”) via its 100% owned subsidiary m2m Ventures Pty Ltd (“m2v”) has agreed to provide a project financing facility and development assistance (JPFDA) to a project developer operating in the South Pacific region and Asia. Read more…
Viewed 20887 times by 623 viewers
November, 2009: Melbourne, Australia: The Trans Tasman Commercialisation Fund (TTCF) has engaged Grannus Securities and Dr Andrew P O’Brien as Senior Investment Manager to lead the fund’s management team while an international search for a Senior Investment Manager is conducted. Dr O’Brien will take up the role focusing on executing operational outcomes and working with the team and member universities to identify projects, complete due diligence and make and manage investments.
Acting Chairman, Winsome Hall said “It has been recognised by the Board that a senior appointment was required in the interim to ensure the continued successful execution of the fund’s investment strategy. Dr O’Brien provides a unique set of skills for the Australasian market bringing international investment advisory, technical understanding and operational expertise in the healthcare market to this role. These skills will be used by the investment management team as they work with our member universities seek to secure investments.” Read more…
Viewed 19813 times by 500 viewers
Adelaide, South Australia (9 November 2009) Acuvax Ltd (ASX: ACU) today announces that it has formally served, on the Board of Hawaii Biotech Inc (“HBI”), a requisition calling for an Extraordinary Meeting of Shareholders.
The purpose of this requisition is to ask HBI shareholders to decide upon a restructure of the HBI Board of Directors to provide a more aggressive approach to the commercialisation of HBI’s vaccine technologies.
The requisition is for the replacement of two current directors, Elliot Parks and Debran Beresini. Read more…
Viewed 19747 times by 579 viewers
Wesfarmers today launched its inaugural Reconciliation Action Plan (RAP).
Managing Director, Richard Goyder, said the RAP was a commitment by Wesfarmers aimed at ensuring that the company’s businesses were places where Aboriginal and Torres Strait Islander peoples felt welcome and valued, as employees, customers and citizens.
“I believe that Wesfarmers, and corporate Australia generally, have a role to play in combating the disadvantage experienced by Aboriginal and Torres Strait Islander peoples in Australia,” he said
The RAP includes a series of specific measurable actions to be undertaken across the Wesfarmers Group and at a Corporate Office level, targeting employment and community engagement. Read more…
Viewed 17587 times by 458 viewers
Profitable fast growing national traffic businesses with bases in WA, SA & Victoria
Melbourne: Traffic signage and street sweeping company The Traffic Group (ASX:TTG) opened its initial public offer (IPO) on 28-10-2009 to raise $5 million. The company is profitable and plans to substantially expand by winning new business, acquiring new businesses and to buy assets from distressed competitors.
The Traffic Group was established in 2007 by managing director Con Scrinis. The strategy of The Traffic Group is to consolidate the fragmented traffic services industry and the IPO fundraising will accelerate the company’s growth. Read more…
Viewed 20155 times by 532 viewers
The national housing industry put on a positive face this week at the Steel Frame Building Expo staged at Yarraville in Melbourne.
According to major exhibitor FRAMECAD™, a number of up-beat signals were given at the Expo that indicate the Australian housing industry’s slump is over – or soon will be.
FRAMECAD™ Regional Sales Manager, Mr Peter Blythe said, “There were four very positive signs:-
- feedback from attendees from the industry through the week consistently referred to a ‘turnaround’ and things looking better in terms of their customer interest and sales
- attendance at the Expo was better than expected with good crowds on most days including tertiary students from Holmesglen TAFE
- attendees mainly asked business-building questions; they were mainly prospective buyers rather than ‘tire-kickers’
- FRAMECAD’s™ sales were good, selling two machines so far this week plus two or three very positive leads that we look forward to converting into sales in coming weeks.”
Read more…
Viewed 18230 times by 399 viewers
Melbourne, October, 2009: Ascent Pharmahealth Limited (APH), via its Australian generics business, Genepharm (Australia) Limited (Genepharm) has today entered into a distribution and services agreement (Agreement) with Pfizer Australia Pty Ltd (Pfizer) to promote and sell the full range of Pfizer’s established off-patent medicines to Australian pharmacies.
The Agreement represents a significant market initiative for both parties for the sale of Pfizer’s off-patent medicines via Genepharm’s marketing and sales force Australia wide.
Under the Agreement, Genepharm will: Read more…
Viewed 19614 times by 506 viewers
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to advise that it has executed an Exclusive Test and Services Agreement with Rosetta Genomics Inc. (“Rosetta”), under which the Company will become the exclusive distributor in Australia, New Zealand and Singapore for Rosetta’s microRNA-based assays. Rosetta, whose headquarters are located in Rehovot, Israel, also operates an accredited laboratory in Philadelphia, USA.
Under the Agreement, GTG will distribute Rosetta’s three recently launched miRview™ tests in Australia, New Zealand and Singapore. By leveraging unique biomarkers called microRNAs, Rosetta’s miRview™ tests can offer patients and physicians new insights on cancer.
“We have made remarkable progress in making our tests so widely available in the short time since they were launched early this year,” said Ronen Tamir, Chief Commercialisation Officer of Rosetta Genomics. “We note that this distribution agreement marks Rosetta Genomics’ first entry into the Pacific Rim and represents the fifth continent on which our miRview™ tests will be sold.” Read more…
Viewed 19441 times by 486 viewers
